Khay
2021-04-10
Why is Quidel falling so much if the earnings has like doubled?
5 Value Stocks In The Healthcare Sector
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":346391939,"tweetId":"346391939","gmtCreate":1617986710821,"gmtModify":1634295349969,"author":{"id":3575509965500620,"idStr":"3575509965500620","authorId":3575509965500620,"authorIdStr":"3575509965500620","name":"Khay","avatar":"https://static.tigerbbs.com/7697911666e72aa44cf5e42a7288913f","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":15,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Why is Quidel falling so much if the earnings has like doubled?</p></body></html>","htmlText":"<html><head></head><body><p>Why is Quidel falling so much if the earnings has like doubled?</p></body></html>","text":"Why is Quidel falling so much if the earnings has like doubled?","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/346391939","repostId":2125766445,"repostType":2,"repost":{"id":"2125766445","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1617631621,"share":"https://www.laohu8.com/m/news/2125766445?lang=&edition=full","pubTime":"2021-04-05 22:07","market":"us","language":"en","title":"5 Value Stocks In The Healthcare Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2125766445","media":"Benzinga","summary":"What are Value Stocks?\n\n","content":"<html><body><h2>What are Value Stocks?</h2>\n<p>A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.</p>\n<h2>Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:</h2>\n<ol>\n<li><strong><a href=\"https://laohu8.com/S/SURF\">Surface Oncology</a></strong> (NASDAQ:SURF) - P/E: 5.15</li>\n<li><strong>Global Cord Blood</strong> (NYSE:CO) - P/E: 7.67</li>\n<li><strong>Quidel</strong> (NASDAQ:QDEL) - P/E: 7.01</li>\n<li><strong>Bio-Rad Laboratories</strong> (NYSE:BIO) - P/E: 4.6</li>\n<li><strong>Endo International</strong> (NASDAQ:ENDP) - P/E: 6.92</li>\n</ol>\n<p>Surface Oncology has reported Q4 earnings per share at 1.56, which has increased by 500.0% compared to Q3, which was -0.39. Surface Oncology does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Global Cord Blood saw a decrease in earnings per share from 0.16 in Q2 to 0.15 now. Global Cord Blood does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Most recently, Quidel reported earnings per share at 11.07, whereas in Q3 earnings per share sat at 5.78. Quidel does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Most recently, Bio-Rad Laboratories reported earnings per share at 4.01, whereas in Q3 earnings per share sat at 3.0. Bio-Rad Laboratories does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>This quarter, Endo International experienced an increase in earnings per share, which was 0.52 in Q3 and is now 0.75. Endo International does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>These 5 value stocks were selected by <strong>Benzinga Insights</strong> based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.</p>\n</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Value Stocks In The Healthcare Sector</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Value Stocks In The Healthcare Sector\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-04-05 22:07</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><h2>What are Value Stocks?</h2>\n<p>A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.</p>\n<h2>Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:</h2>\n<ol>\n<li><strong><a href=\"https://laohu8.com/S/SURF\">Surface Oncology</a></strong> (NASDAQ:SURF) - P/E: 5.15</li>\n<li><strong>Global Cord Blood</strong> (NYSE:CO) - P/E: 7.67</li>\n<li><strong>Quidel</strong> (NASDAQ:QDEL) - P/E: 7.01</li>\n<li><strong>Bio-Rad Laboratories</strong> (NYSE:BIO) - P/E: 4.6</li>\n<li><strong>Endo International</strong> (NASDAQ:ENDP) - P/E: 6.92</li>\n</ol>\n<p>Surface Oncology has reported Q4 earnings per share at 1.56, which has increased by 500.0% compared to Q3, which was -0.39. Surface Oncology does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Global Cord Blood saw a decrease in earnings per share from 0.16 in Q2 to 0.15 now. Global Cord Blood does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Most recently, Quidel reported earnings per share at 11.07, whereas in Q3 earnings per share sat at 5.78. Quidel does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Most recently, Bio-Rad Laboratories reported earnings per share at 4.01, whereas in Q3 earnings per share sat at 3.0. Bio-Rad Laboratories does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>This quarter, Endo International experienced an increase in earnings per share, which was 0.52 in Q3 and is now 0.75. Endo International does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>These 5 value stocks were selected by <strong>Benzinga Insights</strong> based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.</p>\n</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SURF":"Surface Oncology","BIO":"Bio Rad实验室","QDEL":"窥得儿医药"},"source_url":"https://www.benzinga.com/node/20480840","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2125766445","content_text":"What are Value Stocks?\nA value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.\nBenzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:\n\nSurface Oncology (NASDAQ:SURF) - P/E: 5.15\nGlobal Cord Blood (NYSE:CO) - P/E: 7.67\nQuidel (NASDAQ:QDEL) - P/E: 7.01\nBio-Rad Laboratories (NYSE:BIO) - P/E: 4.6\nEndo International (NASDAQ:ENDP) - P/E: 6.92\n\nSurface Oncology has reported Q4 earnings per share at 1.56, which has increased by 500.0% compared to Q3, which was -0.39. Surface Oncology does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nGlobal Cord Blood saw a decrease in earnings per share from 0.16 in Q2 to 0.15 now. Global Cord Blood does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nMost recently, Quidel reported earnings per share at 11.07, whereas in Q3 earnings per share sat at 5.78. Quidel does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nMost recently, Bio-Rad Laboratories reported earnings per share at 4.01, whereas in Q3 earnings per share sat at 3.0. Bio-Rad Laboratories does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nThis quarter, Endo International experienced an increase in earnings per share, which was 0.52 in Q3 and is now 0.75. Endo International does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nThese 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.","news_type":1},"isVote":1,"tweetType":1,"viewCount":242,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":52,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/346391939"}
精彩评论